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Abstract 
A high variability in functional tests and activities used during the
pulmonary rehabilitation has been observed in post-intensive care
unit (ICU) patients, and the best battery of tests to adopt has not been
described yet. We tested in patients admitted in a post-ICU Step Down
Unit the ability to perform the more frequent functional volitional
tests. The relations of each single volitional test with general dis-
ability and dyspnea at discharge were also evaluated. Ten volitional
tests including: bedside spirometry test (ST: FEV1%, FVC%), maximal
inspiratory pressure (MIP), maximal expiratory pressure (MEP),
Peak Expiratory Flow during Cough (PCEF), Quadriceps Muscle
Strength (QMS), latissimus Dorsi and teres Major Strength (DMS),
Brachial biceps Muscle Strength (BMS), effort tolerance measured by
sit-to-stand test, Takahashi test and 6-Min Walking Test (6MWT),
were evaluated in post-ICU patients at entry and discharge from in-
hospital rehabilitation. General disability was assessed by Barthel
Index, while dyspnea by Borg scale.
At admission, >70% of subjects performed muscle strength test,
while <25% performed respiratory and effort tolerance tests. At dis-
charge, feasibility of spirometry, respiratory muscle strength and ef-
fort tolerance tests improved (all, p<0.001); 6MWT was the least fea-
sible. At discharge, cardiorespiratory patients were more capable to
perform tests compared to neurological ones. All outcome measures,
with exception of FEV1%, and FVC%, were significantly related to the
disability score. 
Peripheral muscle exercises showed the highest feasibility, spirom-
etry and leg effort tolerance the lowest. Motor disability was explained
mainly by the peripheral muscle strength. The study of non-volitional
outcome measures and tests linked to a protocol-driven intervention
should be performed in this specific population.
Introduction 
In the last 15 years, availability of beds in intensive care unit (ICU)
and new technologies coupled with improved levels of care have high-
lighted a new category of subjects labeled “ICU survivors” in whom
hospitalization and recovery may be abnormally prolonged [1]. Their
physical disabilities include mainly peripheral and respiratory muscle
wasting, weakness, neuromyopathies and poor nutritional status [2].
Post ICU-discharge care for this population often requires transfer to a
Post-ICU Step Down Unit (P-ICU) [3,4]. Previous reports have shown
that rehabilitation in this population is safe and feasible, involving res-
piratory muscle strength, limb and arm muscles strength, activities of
daily living (ADL) functional scores and effort tolerance [5-8]. Two re-
cent reviews by Elliot et al. [9] and Connolly et al. [10] describe a high
variability in muscle strength evaluations, functional activity tests,
walking assessments, and patient-centered outcomes such as health-
related quality of life in survivors of ICU. The Authors conclude that
sensitivity and validity of measures in survivors of a critical illness
have not yet been established and new tools need to be developed to ap-
propriately assess the weakness and poor physical function in order to
measure effectiveness of interventions [9,10]. In fact, the majority of
studies carried out take into consideration only some aspects of pa-
tient’s disability, but no study has performed a comprehensive and ob-
jective rehabilitative assessment with the most common measures
used in this field to detect their feasibility.
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At (T0) and hospital discharge (T1), subjects underwent ten voli-
tional tests, conducted by a PT consisted of: 
i) a bedside spirometry test (ST) to measure the FEV1 and FVC with
a portable spirometer (V Max, Sensormedics; Carefusion, Franklin
Lakes, NJ, USA) [12];
ii) maximal inspiratory pressure (MIP);
iii) maximal expiratory pressure (MEP) according to the method of
Black and Hyatt [13] with a portable differential pressure trans-
ducer (Honeywell 300 manometer; Freeport, IL, USA) using a
flanged mouthpiece [14]; 
iv) peak cough expiratory flow (PCEF) with a peak flow meter (Mini-
Wright, Clement Clarke International Ltd., Harlow, UK) using a
flanged mouthpiece or an oro-nasal mask (Cristal, Koo Industries
Co., Ltd., Shanghai, China) [15,16]; 
v) quadriceps muscle strength (QMS);
vi) brachial biceps muscle strength (BMS);
vii) latissimus dorsi and teres major muscle strength (DMS); 
All peripheral muscle function evaluations were carried out by a
manual test using the Medical Research Council (MRC) scale to
measure the range of muscle strength, with score ranging from 0
(no visible or palpable muscle contraction) to 5 (movement
through the complete range of motion against gravity and max-
imum resistance) [17]. One leading muscle, possibly on the dom-
inant limb, was tested: QMS was performed in sitting or supine po-
sition depending on the patient’s clinical condition, as recom-
mended by Hough et al. [18]. DMS and BMS were tested in lateral
decubitus or in a sitting position as previously recommended [19];
viii) effort tolerance measured by the 30-second sit-to-stand test per-
formed using a 43-cm high chair without arm rests as described
by Jones et al. [20]. Subjects were asked to rise from the chair and
sit down as many times as possible without using the arms as a
support. The number of completed repetitions in 30 seconds was
recorded;
ix) effort tolerance measured by an incremental test for unsupported
upper limbs as described by Takahashi et al. [21] was used. The
total duration (seconds) of the test was recorded; 
x) effort tolerance measured by the 6-minute walk test (6MWT) ac-
cording to international guidelines [22]. The total distance (me-
ters) reached was recorded.
Inability to perform a test (in which case 0 points were assigned)
included: 
1. low level of consciousness and cognitive functions (GCS <10) [23]; 
2. low compliance with instructions given for each test;
3. limitation in performing the assessments as follows: i) during
spirometry tests, the patient did not generate flow detectable by
the spirometer or was totally dependent (H 24) on mechanical ven-
tilation; ii) during respiratory muscle strength tests, the patient
was not able to sustain the effort for at least 1.5 seconds, or was
unable to perform three maneuvers with less than 20% of differ-
ence between the values [13] or was totally dependent (24/24 h)
on MV; iii) during PCEF, the patient was not able to stake retain
air in the lung closing the glottis or was not able to produce at
least three attempts with values differing less than 40 L/min [24];
iv) the peripheral muscle strength value was 0 (no visible/palpable
contraction); v) during 30 seconds sit-to-stand test, the patient
was not able to reach and maintain the sitting position or needed
arm aid or external help to reach the standing position; vi) during
the Takahashi test, the patient was not able to reach and/or main-
tain the sitting position or was unable to perform the test cor-
rectly; vii) during the 6MWT, the patient was not able to walk alone
or for more than 20 meters or was totally dependent (24/24 h) on
mechanical ventilation.
To this aim, in patients who underwent P-ICU rehabilitation, we pro-
posed a multidimensional assessment to evaluate: i) rate subjects’
ability to perform each test at admission and discharge analyzing the
difference according to diagnosis; and ii) the relationship of each
single volitional test with general disability and dyspnea at discharge.
Materials and Methods
All study procedures were carried out in conformity with the Decla-
ration of Helsinki. The institutional review board (Istituti Clinici
Maugeri IRCCS, deliberation N° 751) approved the study. Written in-
formed consent was obtained from all participants. 
Design
This was a cohort prospective observational study. 
Participants
From January 2010 to June 2011 we enrolled all consecutively dis-
charged post-acute critical care patients who had: i) a recent (≤3
months) episode of acute respiratory failure (ARF); ii) an ICU stay of
at least 20 consecutive days with difficulty weaning from mechanical
ventilation (MV); iii) completed a P-ICU rehabilitation program. Fol-
lowing critical care, the P-ICU rehabilitation program consisted of clin-
ical stabilization, weaning attempts from MV by progressively reducing
inspiratory support or increasing time of spontaneous breathing, and
individualized/integrated physiotherapy administered by a dedicated
physiotherapist (PT) who provided an individually-tailored program of
passive and active assisted exercises and mobilization, maintenance of
body posture, electrical stimulation of leg muscles, sitting and standing
postural exercises, limb strength/endurance training by cycle er-
gometer or treadmill, walking assistance, lung volume recruitment, and
bronchial hygiene. The intervention was 1 hour/day which could be per-
formed as a single or in two 30-min sessions 6 days per week. Besides
possible need for MV, supplemental oxygen was administered to main-
tain oxy-hemoglobin saturation (O2 sat) greater than 90% during exer-
cise. The respiratory assistance was gradually reduced over time and
the PT constantly monitored the patient for signs of cardiorespiratory
distress during the sessions.
Patients were excluded if they: were under 18 years of age, had car-
diovascular instability, amyotrophic lateral sclerosis, remained criti-
cally ill, had electrodiagnostic evidence of myopathy/polyneuropathy,
had multi-organ failure, required hemodialysis, had a life expectancy
less than 6 months, lived more than 80 km from the study center, were
transferred to another hospital or nursing home, refused to participate,
or were enrolled in other trials. The multidisciplinary rehabilitative
program was based on a close collaboration between doctors, nurses
and physiotherapists. The details of the program are described else-
where [8].
Outcomes measures
All patients were tested in a P-ICU rehabilitation unit from the Isti-
tuti Clinici Maugeri IRCCS of Lumezzane (BS). At admission (T0), the
following parameters were collected:
• Anthropometric data, e.g. age, gender, body mass index (BMI) 
• APACHE II score 11
• Main diagnosis, based on which subjects were subdivided into two
main groups (cardiorespiratory diseases and neurological diseases) 
• Presence of tracheostomy
• MV use for weaning attempts
pimeEDITRICE
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Figure 1. Flow chart of the study.
In addition, at T0 and T1, the general motor disability and dyspnea
were recorded using the Barthel index (score ranging from 0 = totally
dependent to 20 = totally independent) [25] and BORG scale (0 = no
dyspnea, 10 = maximal dyspnea) [26].
Data analysis 
Statistical analyses were performed using the software package
STATA 12.1 (StataCorp LP, USA). All variables were expressed as mean
and standard deviation (SD) or as a percentage. The change obtained
by the patients able to execute the rehabilitation tests at admission and
discharge was analyzed using chi-square test. 
Univariate linear regression analysis was performed on data at dis-
charge to show relation between volitional tests and Barthel Index or
Dyspnea Score (Borg score). For all statistical tests a p-value <0.05 was
considered as statistically significant.
Results
From January 2010 to June 2011, 67 subjects were enrolled as described
in Figure 1. Their main clinical characteristics were shown in Table 1.
Subjects were middle aged, half of them presented neurological dis-
eases (stroke 52%, post cardiac arrest 15%, Guillain-Barré syndrome
7%, non-degenerative neuromuscular diseases 18%, Parkinson’s dis-
ease 4%, and astrocytoma 4%); they had an ICU stay longer than 30
days; most required tracheostomy (72%) or MV use (60%), while clin-
ical conditions were stable. 
Figure 2 describes the overall rate of feasibility (panel A), i.e. “per-
formability”, of each rehabilitative volitional test administered at ad-
mission and discharge and the rate of feasibility in cardiorespiratory
and neurological patients (panel B and C, respectively). At admission,
only peripheral muscle evaluations showed a good overall feasibility
(70%), i.e. they could be performed by most subjects, while few subjects
(less than 25%) could perform the respiratory and effort tolerance
tests. In particular, no one could perform the 6MWT. At discharge, the
overall feasibility of respiratory function, respiratory muscle tests and
effort tolerance tests improved significantly (p<0.001). At discharge, all
peripheral muscle tests were highly feasible; respiratory muscle and
arm effort tolerance tests could be carried out by more than 50% of sub-
jects, while the spirometry test, PCEF and sit-to-stand test were slightly
performable. The 6MWT showed the least overall feasibility, i.e. only
25% of subjects at discharge were able to perform it. 
Concerning differences between cardiorespiratory and neurological
patients, at the admission the only volitional tests significantly dif-
ferent (p<0.001) in performability were QMS, BMS and DMS that were
higher in cardiorespiratory patients compared to neurological ones. On
the contrary, at the discharge cardiorespiratory patients were signifi-
cantly more able to perform all the measures compared to neurological
ones (p<0.05) (Table 2, Figure 2).
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Figure 2. Percentage of subjects defined as able to perform each test
(for details see methods) at admission (T0, white bars) and at dis-
charge (T1, black bars) of P-ICU unit. ^p<0.05; °p<0.02; *p<0.001
vs T0. ST: spirometry test; MIP: maximal inspiratory pressure;
MEP: maximal expiratory pressure; PCEF: peak cough expiratory
flow; QMS: quadriceps muscle strength; BMS: biceps muscle
strength; DMS: latissimus dorsi and teres major muscle strength;
6MWT: six-minute walking test.
Table 1. Characteristics of the studied subjects at admission to our
rehabilitation unit.
Characteristics
Enrolled subjects, n 67
Age (years), mean (SD) 66 (12)
Males, % 52
BMI, kg/m2, mean (SD) 26 (5)
Diagnosis
Neurological diseases n, % 27 (40)
Cardiorespiratory diseases n, % 40 (60)
Post cardiac surgery n, % 13 (19)
ARF n, % 12 (18)
COPD n, % 15 (22)
ICU LOS, days, mean (SD) 36 (39)
Rehabilitation unit LOS, days, mean (SD) 86 (66)
pH, mean (SD) 7.44 (0.07)
PaO 2/FiO2, mean (SD) 253 (84)
PaCO2, mmHg, mean (SD) 51 (14)
Apache II score, mean (SD) 12.0 (5.7)
Tracheostomized, n (%) 48 (72)
Ventilated, n (%) 40 (60)
BMI: Body Max Index; ARF: Acute Respiratory Failure, FiO2: Inspiratory rate of oxygen, LOS: length of stay;
PaO2: partial pressure of oxygen; PaCO2: partial pressure of carbon dioxide.
Subjects performed 240 (SD 196) rehabilitation sessions during the
86 (SD 66) days of stay in the rehabilitation facility. In-hospital mor-
tality was observed in 7 subjects (10%) and the drop-out rate (due to 3
subjects’ transfer to another hospital) was 4%. 
Forty percent of subjects had ventilated through tracheostomy at T0
and 19% still required MV at T1. Table 2 describes value of volitional
measures in survived patients that were able to carry out volitional
tests. 
Table 3 reports univariate regression models between the Barthel
Index and all the volitional tests evaluated at discharge. All outcome
measures with the exception of spirometry (FEV1%, and FVC%) were
significantly related to the disability score. As described by the re-
gression coefficient (Table 3), peripheral muscle tests were the
measures with the highest added effect on disability. Only spirom-
etry (FEV1%, and FVC%) and cough ability (PCEF) were significantly
related to the Dyspnea Borg Score in the univariate regression model
(e.g., dyspnea versus all the volitional tests), but their impact on de-
pendent variable is probably clinically not so relevant as evidenced by
the very low power of the model (FEV1% regression coefficient -
0.036, R2 0.278, p=0.009, FVC% regression coefficient -0.036, R2
0.198, p=0.029, PCEF regression coefficient -0,012, R2 0.381,
p=0.002; Table 4).
Discussion
In a sample of subjects with a recent ICU stay and discharged from a
rehabilitation facility, the present study has shown that: i) among dif-
ferent volitional tests, peripheral muscle evaluations result the most
feasible, while spirometry and leg effort tolerance were the least fea-
sible; ii) at discharge, cardiorespiratory patients were generally more
able to perform tests compared to neurological patients; iii) motor dis-
ability is explained mainly by peripheral muscle strength; iv) dyspnea
is explained mainly by respiratory function tests. 
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Critical illness and treatment may cause a decline in subjects’ func-
tional capacity, which affects the recovery trajectory for ICU survivors
[27]. Despite that, in the rehabilitative approach to post-critically ill
subjects there are no standard outcome measures, and often only motor
disability is used without any objective and volitional test. In particular,
respiratory function tests, and cardiorespiratory disability assessment
at rest and during exercise are often underused [9]. No study has de-
scribed a complete, objective and volitional rehabilitative evaluation of
general and respiratory disability; instead, in this field subjective
measures such as questionnaires or scales are often used per se [9].
The execution of volitional tests is often difficult in this population as
such tests require strong patient participation. However, volitional
tests may represent an added value for the rehabilitative setting in that
they offer information about specific single functions or activities (e.g.,
walking ability, ability to reach/maintain upright position, functional
use of upper limbs, etc.) and allow a greater estimate of the risk of
complications and more information for selecting the most appropriate
rehabilitation program. For this reason, we considered several voli-
tional tests, commonly used as outcomes of a rehabilitative program, in
a unique triage package. These tests may be used to guide global reha-
bilitative assessment and needs in post-critically ill subjects. 
Spirometry is the most important measure for determining severity of
airway obstruction (FEV1) and lung function (FVC) [28]. The FEV1 and
FVC values are currently used in the diagnosis, staging and treatment of
COPD, both being measurements that are highly reproducible [12]. MIP
and MEP are indirect measures of respiratory muscle strength [13], while
PCEF reflects the patient’s ability to protect airways and remove secre-
tions [15]. Peripheral muscle function was tested by manual muscle
testing [MMT)] using the MRC scale [18] and describing one leading
muscle for the upper limb, lower limb and trunk districts. Although the de-
bate is open about the best methodology to use, MMT is currently the pre-
ferred diagnostic tool for evaluating the presence of ICU-acquired weak-
ness [9] has proven reliability [29], and shows a high inter-observer
agreement [30]. The improvement in effort tolerance is one of the main
goals of pulmonary rehabilitation also in subjects who have survived a
long stay in the ICU [31]. The sit-to-stand test is less stressful, less likely
pimeEDITRICE
Table 2. Value of volitional measures in patients who were able to perform the tests.
Overall Cardiorespiratory patients Neurological patients
T0 T1 T0 T1 T0 T1
Mean (sd) n Mean (sd) n Mean (sd) n Mean (sd) n Mean (sd) n Mean (sd) n
FEV1, % 32.2 (23.6) 5 59.6 (29.0) 25 32.2 (23.6) 5 58.8 (29.1) 20 ------ 0 62.8 (31.5) 5
FVC, % 58.4 (21.1) 5 69 (24.6) 25 58.4 (21.1) 5 68.8 (24.4) 20 ------ 0 70.0 (27.9) 5
MIP, cmH2O 37 (10.1) 4 44.9 (20.2) 35 37 (10.1) 4 51.5 (19.1) 25 ------ 0 28.6 (12.3) 10
MEP, cmH2O 59.3 (17.7) 4 54.1 (29.4) 36 59.3 (17.7) 4 58.23(27.43) 26 ------ 0 43.2 (33.2) 10
PCEF, L/min 120.0 (36.7) 9 205.8 (120.7) 28 138.3 (23.2) 6 217.4 (100.2) 24 83.3 (32.1) 3 162.0 (111.2) 4
QMS, Kg 2.92 (0.79) 49 3.88 (0.89) 58 2.86 (0.81) 38 4.15 (0.54) 40 3.18 (0.68) 11 3.34 (1.19) 18
BMS, Kg 3.12 (0.87) 51 3.99 (0.96) 59 3.15 (0.83) 38 4.36 (0.56) 40 3.01 (0.97) 13 3.33 (1.16) 19
DMS, Kg 2.77 (1.04) 49 3.88 (0.89) 56 2.17 (1.05) 37 4.17 (0.66) 40 2.97 (1.01) 12 3.32 (1.40) 16
Sit-to -stand, repetitions 15.5 (7.8) 2 13.28 (7.7) 21 15.5 (7.8) 2 13.3 (7.7) 18 ------ 0 11.8 (9.2) 3
Takahashi, seconds 119 (58) 8 181 (99) 35 129 (62) 6 176 (105) 29 88 (46) 2 200 (81) 6
6MWT, meters ------ 0 294 (92) 17 ------- 0 278 (70) 15 ------ 0 390 (184) 2
ST: spirometry test; MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure; PCEF: peak cough expiratory flow; QMS: quadriceps muscle strength; BMS: biceps muscle strength; DMS: latissimus dorsi
and teres major muscle strength; 6MWT: six-minute walking test; T0: at admission; T1: at discharge; %: percentage of predicted value; cmH2O: centimeters of water; L: liters; Min: minutes; n: number of patients who
were able to perform the volitional measure; ------: patients unable to execute the tests.
Table 3. Univariate regression model of Barthel Index as dependent
variable: relationship with each volitional test evaluated at
discharge. 
Models Slope t P-value R2
coefficient
FEV1 % pred 0.06 1.38 0.18 0.11
FVC % pred 0.05 0.74 0.06 0.47
MIP % pred 0.19 4.3 <0.002 0.29
MEP % pred 0.12 2.9 0.006 0.27
PCEF, L/min 0.02 2.1 0.047 0.17
QMS score 3.72 14.8 <0.001 0.65
BMS score 3.69 12.1 <0.001 0.60
DMS score 3.58 14.0 <0.001 0.63
Sit-to-stand, n of repetitions 0.68 7.6 <0.001 0.46
Takahashi, seconds 0.05 9.0 <0.001 0.59
6MWT, meters 0.04 8.3 <0.001 0.41
MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure; PCEF: peak cough expiratory
flow; QMS: quadriceps muscle strength; BMS: biceps muscle strength; DMS: latissimus dorsi and teres
major muscle strength; 6MWT: six-minute walking test.
Table 4. Univariate regression model of Dyspnea Perception (Borg
Score) as dependent variable: relationship with other covariates
(volitional tests) at discharge. 
Models Slope t P-value R2
coefficient
FEV1 % pred -0.036 -2.87 0.009 0.273
FVC % pred -0.036 -2.33 0.029 0.198
MIP % pred -0.038 -2.02 0.052 0.113
MEP % pred -0.0216 -1.69 0.101 0.070
PCEF, L/min -0.012 -3.59 0.002 0.381
QMS score 0.023 0.09 0.926 0.0002
BMS score -0.01 -0.04 0.968 0.0000
DMS score -0.0009 -0.04 0.971 0.0000
Sit-to-stand, n of repetitions -0.04 -0.81 0.424 0.010
Takahashi, sec -0.005 -1.60 0.116 0.050
6MWT, meters -0.006 -2.16 0.036 0.082
MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure; PCEF: peak cough expiratory
flow; QMS: quadriceps muscle strength; BMS: biceps muscle strength; DMS: latissimus dorsi and teres
major muscle strength; 6MWT: six-minute walking test.
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spirometry and leg effort tolerance were the least feasible. The per-
formability of the tests increased over time and, at discharge, the motor
disability was mainly related to peripheral muscle strength. Specific
improvement (i.e., increase in 6 MWT) was found only in some patients
suggesting that the tests should be tailored patient by patient to reach
the more proper rehabilitative outcome. 
This low viability describes the need of new objective outcome meas-
ures (also non-volitional) that might be administered in patients that are
not able to perform some of them at the beginning of rehabilitation. Fu-
ture studies should investigate whether the evaluation of these patients
might be linked to a protocol-driven intervention with the aim to produce
better rehabilitation outcomes in this specific population.
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to cause hemodynamic variation, easier to apply and more informative
than the 6MWT [32,33]. The Takahashi Test is an unsupported incre-
mental upper limb exercise test that reflects the arm use during activities
of daily living: it is validated and reproducible [21]. The 6MWT is the most
frequently used field test: it is validated and standardized, it is relatively
simple to perform, well tolerated and reflects everyday activity [34], and
it correlates with lung function, health status, and maximal VO2 [34].
All the proposed measures are based on the assumption that subjects
can collaborate actively in performing the maneuver. We maintain that
many critically ill subjects are not able to perform one or more of these
tests in the first few days of rehabilitation in a hospital facility, while
they may be able to do so at the time of discharge. We also believe that
the inability per se to perform volitional tests is an important clinical in-
dicator and can be used as a measure of outcome, to assess the indi-
vidual’s rehabilitation needs and to allocate subjects to different inter-
ventions or rehabilitation facilities. 
As expected, i) at baseline only a small number of subjects was able
to perform respiratory function and effort tolerance tests, whereas a
larger number of subjects had sufficient muscular activity to be able to
perform dedicated tests in selected peripheral muscles at the same time
(Figure 1); ii) at discharge, a large number of tests were completed with
higher scores obtained; however more than 70% of subjects were still
unable to perform leg effort tolerance tests, while more than 50% were
unable to perform the arm effort tolerance tests demonstrating the ob-
jective high residual disability of this category of subjects; iii) at dis-
charge there was a significant difference in ability to perform all tests
between cardiorespiratory and neurological patients. This fact implies
that each individual patient may have a different response to hospital
rehabilitation intervention, and possibly requires a different approach
or more time to reach a specific goal in each domain. 
The relationship between peripheral muscle measures and Barthel
Index, as well as between respiratory functional tests and dyspnea don’t
surprise us and supports the great necessity of a global assessment.
Clinical implications
The application of volitional tests - evaluating outcomes commonly
used in a pulmonary rehabilitation program - is of clinical importance be-
cause allows to face up to different aspects of the physical and respira-
tory disability. However, the feasibility of those tests in the P-ICU setting,
both at admission and discharge, in general has been shown to be low. 
For these reasons, the package of evaluation tests administered
during the pulmonary rehabilitation program in P-ICU should be tai-
lored to the single patient, identifying his/her specific abilities and
needs for rehabilitation (i.e., of the upper limbs, lower limbs, or respi-
ratory muscles), being a global assessment not viable. The introduction
of new outcome measures including non-volitional tests (i.e., cross sec-
tional muscular area, p-twitch of diaphragm muscle, etc.) that may be
administered to everyone should also be argued.
Limitations
The main limitation of this study concerns its observational nature.
No specific test to diagnose “ICU-acquired” weakness was conducted. 
Conclusions
For the first time, multiple volitional rehabilitation evaluations were
carried out in P-ICU subjects undergoing a rehabilitation program to
determine which type of physical rehabilitation intervention was fea-
sible for post-critical illness patients. At admission, peripheral muscle
evaluations were proved to be the most feasible volitional tests, while
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